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Synthesis of Nitrogen Heterocycles and 
Ruthenium Complexes 
JOHAN R. JOHANSSON 
Department of Chemical and Biological Engineering 
 
C H A L M E R S  U N I V E R S I T Y  O F  T E C H N O L O G Y  
 
ABSTRACT 
    Because of the diverse properties displayed by nitrogen heterocycles, they are one of the most 
commonly used structural elements in drug discovery. Due to this variation in properties, 
however, the chemistry and synthetic pathway to each heterocycle is unique. This is one of the 
reasons why heterocyclic chemistry is still an important and interesting research field for 
organic chemists today. Many ruthenium complexes exhibit versatile properties which make 
them useful tools as catalysts, and several of them can also be applied in the creation of 
interesting nitrogen heterocycles.  
    One of the main parts of this thesis concerns the synthesis of 1,5-substituted-1,2,3-triazoles 
via the ruthenium catalyst azide-alkyne 1,3-dipolar cycloaddition reaction (RuAAC). Several 
different ruthenium complexes have been employed, and a convenient and safe sequential one-
pot microwave procedure has been developed for the RuAAC reaction. The tolerance of several 
functional groups present on the substrates has been studied, and the [RuCl2Cp*]x catalyst 
showed remarkably good results in this context. Moreover, 1,5-substituted-1,2,3-triazoles have 
been applied towards foldamer peptidomimetics by constructing oligomers such as a dimer, 
trimer and tetramer of the 5Tzl unit. The secondary structure of the 5Tzl-trimer was studied by 
2D NOESY experiments and quantum chemical calculations, which concluded that the 5Tzl-
trimer is flexible, and that several conformers are present in DMSO solution at 25 °C, where 
two helical structures (H10 and H16) together with three turn-like structures (T1-3) are the most 
probable conformers. From our initial study it can be concluded that oligomers of 5Tzl can 
serve as good adaptable foldamer backbones which can adopt various secondary structures and 
offer improved properties such as water solubility. 
    The synthesis of other nitrogen heterocycles such as pyrrolidines, imidazoles and phenazines 
for various purposes are also demonstrated. Synthesis of a the new luminescent Ru-complex [µ-
bidppze(phen)4Ru2]4+ for DNA threading intercalation studies has been carried out, and this 
complex revealed faster association and slower dissociation kinetics compared to previous 
analogues. Functionalization of carbon nanotubes (CNTs) with active azide functional groups 
has been applied on a silicon-metal chip, via a 1,3-dipolar cycloaddition of an azomethine ylide 
to the CNTs. The functionality of these azide groups was also demonstrated by introduction of 
fluorine via the copper catalyzed azide-alkyne 1,3-dipolar cycloaddition reaction (CuAAC), and 
this initial study displays the potential of this methodology for applications such as biosensors 
in the future.     
Keywords: 1,2,3-triazole, ruthenium-complex, 1,3-dipolar cycloaddition, microwave heating, 
azide, alkyne, RuAAC, CuAAC, foldamers, peptidomimetics, [RuCl2Cp*]x, 2D NOESY, DNA 
threading intercalation, azomethine ylide, functionalized CNT    
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Preface 
 
 
Nitrogen heterocycles in natural products and pharmaceuticals 
Nitrogen heterocycles exhibit an exceptional diversity of properties, and it is no surprise that they are 
so popular in nature where Darwinian combinatorics has successfully exploited their many qualities.  
Evolution has efficiently utilized nitrogen heterocycles as key substances in many species, in both 
plants and animals, in the form of venoms, vitamins, DNA/RNA, co-factors, proteins, pheromones etc. 
Nitrogen heterocycles are a common attribute in natures alkaloids, which are popular and challenging 
targets in total synthesis for the synthetic chemist. Tubocurarine, morphine, batrachotoxin, epibatidine, 
quinine, caffeine, sparteine, and nicotine are just a few examples of the endless number of alkaloids 
containing nitrogen heterocycles produced by Mother Nature.          
Nature is an obvious source for inspiration when it comes to molecular architecture and due to the 
diversity of properties displayed by nitrogen heterocycles, they are also probably one of the most 
commonly used structural elements in drug discovery and pharmaceutical development. Of the top 
200 pharmaceutical products (by sales) in 2009, compiled by the Hjardarson group,1 79% are 
small molecules and 73% of them contain at least one heterocycle. One of these is Tazocin, a 
combination drug of piperacillin and tazobactam, which has activity against many gram-
positive and gram negative pathogens and anaerobes. Tazobactam contains three heterocyclic 
rings and one of these is the 1H-1,2,3-triazole, shown in Figure 1. Another triazole-containing 
drug is Ticagrelor (Figure 1), the first reversible platelet aggregation inhibitor (P2Y12 
antagonist) on the market for the prevention of thrombotic events in patients with acute 
coronary syndrome or myocardial infarction with ST elevation.2 
 
Figure 1. Structure of Piperacillin, Tazobactam and Ticagrelor, which contain several interesting heterocycles. 
The chemistry and synthetic pathway to each heterocycle is unique. This is one of the reasons 
why heterocyclic chemistry is still an important and interesting research field for organic 
chemists today. Many ruthenium complexes exhibit versatile properties which make them 
useful tools as catalysts as well as probes, and several of them can also be applied in the 
creation of interesting nitrogen heterocycles. These are some of the reasons leading up to the 
focus of this thesis, namely the synthesis and applications of nitrogen heterocycles and 
ruthenium complexes in different contexts. 
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1 Introduction to Nitrogen Heterocycles  
 
 
1.1 Definition and properties 
So what is a nitrogen heterocycle? A heterocycle is by definition a cyclic compound 
consisting of at least two different elements. The ring size can vary from three and upwards, 
however the most common ring sizes are 3-7. Usually the term macrocycle is used when the 
ring size exceeds nine. The ring system can be saturated or unsaturated. If it is fully 
unsaturated, the heterocycle is in most cases also aromatic. Consequently, a nitrogen 
heterocycle is a cyclic ring system containing one or more nitrogen atoms.3 The structures of 
saturated 3-7-membered heterocycles containing one nitrogen atom are shown in Figure 4.  
 
Figure 2. pKa of saturated 3-7-membered nitrogen heterocycles.  
Aziridines are less basic than acyclic amines due to the increased s character of the nitrogen 
lone pair. The conjugate acid of aziridine has a pKa value of 7.98 compared to a typical pKa 
value of approimately 11 for the conjugate acid of an acyclic secondary amine.4 Azetidine 
(11.29), pyrrolidine (11.27)5 and piperidine (11.22)6 on the other hand are slightly more basic 
compared to the acyclic diethylamine (10.73). However, when the ring size is further 
increased to the 7-membered ring, azepane (10.30),7 the pKa drops below the pKa of the 
acyclic diethylamine. Heterocycles may have different degree of unsaturation, and examples 
for 5- and 6-membered nitrogen heterocycles are shown in Figure 3.  
 
Figure 3. Examples of unsaturation in nitrogen heterocycles. 
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The fully unsaturated 6-membered nitrogen heterocycle, pyridine, is aromatic and is a weak 
base. Pyridine has a much lower pKa value (5.25) of the conjugate acid compared to 
piperidine.8 Pyrrole on the other hand is not basic at all (pKa ~ -4), since the nitrogen lone pair 
is part of the aromatic system and delocalised in the ring. A protonation of pyrrole results in 
loss of the aromaticity and is highly unfavourable. On the other hand, the pyrrole ring is 
electron rich in itself, and its charge separated tautomers can act as nucleophiles and react 
with electrophiles to form 2-substituted pyrroles as the major product (Figure 4), although 
mixtures of the 2- and 3- regioisomer can be formed. Direct N-substitution is generally not 
possible, but the hydrogen on the pyrrole nitrogen is a weak acid, with a pKa value of 15.8, 
and can be deprotonated with a strong base. The formed anion is resonance-stabilised over the 
whole ring, and a reaction of the pyrrole anion with an electrophile will usually result in the 
N-substituted pyrrole as major product. If one wants to obtain the 3-substituted pyrrole, one 
way to prepare it is to use a sterically hindered protecting group on the pyrrole nitrogen, such 
as triphenylmethyl (Tr) which favours the formation of the less sterically hindered 3-
substituted pyrrole.  
 
Figure 4. Possible strategy to control the regioselectivity in pyrrole chemistry. 
Another example of problems with the formation of regioisomers concerns the alkylation of 
1,2,4-triazoles. The anion is resonance stabilized over the ring and all three nitrogen atoms 
can react. If one of the carbons is substituted, alkylation can lead to the formation of three 
different regioisomers, as shown in Figure 5. The properties of the substituent on the ring will 
affect the ratio between the product isomers. Also, reaction conditions such as solvent and/or 
base may favour the formation of one isomer over the others. There are thus ways to control 
the regioselectivity. However, the reactivity and selectivity are not the same when going from 
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one heterocycle to another. Each heterocycle has its own unique properties and this is 
probably why heterocycles are so popular in drug discovery.  
 
Figure 5. Alkylation of 1,2,4-triazole results in a mixture of regioisomers. 
There is a wide range of nitrogen heterocycles known in the literature and some of the most 
common 5-membered nitrogen heterocycles are shown in Figure 6. Note that all aromatic 5-
membered nitrogen heterocycles except pyrrole are named –azoles. The suffix in the name of 
the nitrogen heterocycle denotes the degree of saturation, i.e. -le, -line, -lidine. As can be 
divined from the name, diazoles contain two nitrogens, and there are many different diazoles 
known in the literature.  
 
Figure 6. The most common 5-membered nitrogen heterocycles. 
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1.2 Imidazoles 
One the many possible structures of diazoles is the imidazole (1,3-diazole), which is a weak 
base (pKa ~7.0) which is taken advantage of in the useful synthetic amide coupling reagent, 
carbonyldiimidazole (CDI),9 as well as in Nature, since histidine residues are frequently 
important in the mechanisms of enzyme catalysis. The saturated version of imidazole, 
imidazolidine is usually not so stable and will be easily hydrolysed into the corresponding 
diamine and aldehyde. However there are many examples of stable imidazolines and 
imidazolidines, in the form of N-heterocyclic carbenes (NHC) coordinated to a transition 
metal (Pd and Ru most commonly).10,11 One example is in the palladium catalyst PEPPSI, 
shown in Figure 7, which is a popular catalyst in Buchwald–Hartwig aryl aminations.12 
 
 
Figure 7. Pd-PEPPSI (Pyridine, Enhanced, Precatalyst, Preparation, Stabilization and Initiation) precatalyst 
complexes 1 and 2, and use of 1 in Buchwald – Hartwig aryl aminations of heterocycles.12 
 
1.3 Triazoles 
The number of different triazole heterocycles is more limited as compared to diazoles. The 
1,2,4-triazole, described earlier, and the 1,2,3-triazole are the two most common forms of 
triazoles. The synthetic route to Ticagrelor (Figure 2) described in the introduction, involves 
28 synthetic steps and in one of these the 1,2,3-triazole is formed.13 By employing 
diazotization conditions on the diaminopyrimidine and subsequent in situ cyclization of the 
formed diazonium-intermediate, the 3H-[1,2,3]triazolo[4,5-d]pyrimidine was obtained in 88% 
yield, as shown in Figure 8.  
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Figure 8. Synthesis of the 1,2,3-triazole unit in the synthesis route to Ticagrelor.13 
 
Other synthetic routes to 1,2,3-triazoles will be discussed in more detail in later chapters of 
the thesis. 
 
1.4 Tetrazoles 
There are only a few possibilities for different tetrazole structures since there is only one atom 
which is not nitrogen. The most common tetrazole is the 5-substituted 1H-tetrazole, which is a 
bioisostere to carboxylic acids, and utilized as the active structure of the sartans. Sartans are a 
class of compounds, AT1-receptor antagonists, used for the treatment of hypertension, chronic 
heart insufficiency condition after a heart attack, and diabetic nephropathy. Examples of 
bioisosteric replacements in the sartan family are shown in Figure 9, together with an example 
of how the tetrazoles can be synthesized from arylnitriles and NaN3.14 
 
 
Figure 9. Bioisosteric replacement of a carboxylic acid functionality into a 1H-tetrazole, commonly used in the 
sartan family. An example of how the crucial tetrazole can be synthesized is also shown.14 
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Another tetrazole structure is the tetrazolinone, which can be synthesized via the reaction of 
an isocyanate with an azide (NaN3 or TMSA), as shown in Figure 10. Phenyl tetrazolinone 
derivatives are used as herbicides in rice fields for example.15-17 Pentazole is an extremely rare 
heterocycle, probably due to its high energy and instability. It can, however, be synthesised 
from aryldiazonium chlorides and azide ion at – 80 °C.18 
     
 
Figure 10. Synthesis of phenyl tetrazolinone derivatives used as herbicides in rice fields.18  
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2 Ruthenium complexes 
 
 
2.1 Ruthenium history, mining and isolation   
Ruthenium is a white silvery metal and is one of the six elements that together with Os, Rh, Ir, 
Pd and Pt forms the platinum group metals (PGMs), located in Group 8-10 (period 5 and 6) of 
Mendeleev’s periodic table. Ruthenium was first isolated by Klaus19-20 in 1844, in residues 
left after crude platinum ore from the Urals had been dissolved in aqua regia. It is named after 
Ruthenia, the Latin name for Rus’ which is the medieval name for today’s west Russia. The 
natural abundance of ruthenium in the earth’s crustal rock is estimated to be only 0.0001 ppm, 
making it a rare element. Ruthenium is generally found in the metallic state along with the 
other PGMs and the coinage metals (Cu, Ag and Au). The major source of ruthenium is the 
nickel-copper sulfide ore found in South Africa and Sudbury in Canada and also in the river 
sands of the Urals in Russia.21 Despite the rarity of ruthenium, it is much less expensive 
(~75$/oz or ~16 kr/g, aug 2013) than Rh, Ir, Pd and Pt, and a price comparison can be seen in 
Figure 11. The reason for the lower price of ruthenium is mainly because the demand is much 
lower, and also the fact that ruthenium is produced as a by-product from copper and nickel 
mining and processing, and from the processing of platinum group metal ores. About 20 
tonnes of ruthenium is produced every year.  
 
Figure 11. Price comparison of Ru with other Platinum metals. Monthly average price in $/oz over the last three 
years. (1 troy ounce, oz = 31.103 g) 
All the platinum group metals (PGMs) are isolated from platinum concentrates which are 
commonly obtained either from electrolytic refining of nickel, copper, silver and gold (where 
PGMs settle to the bottom of the anode solution) or from melting of sulfide ores.22 The 
platinum concentrates are initially treated with hydrochloric acid and chlorine, yielding the 
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volatile tetraoxides of Ru (RuO4) and Os (OsO4), which can be distilled off. The ruthenium is 
separated from osmium by further distillation or by precipitation as ammonium 
hexachlororuthenates (mixtures of isomers), (NH4)3RuCl6, by treatment with ammonium 
chloride. Reduction of the isomeric mixture of (NH4)3RuCl6 with hydrogen leads to a Ru-
metal powder that can be treated using powder metallurgy techniques or argon-arc welding.  
The major use of ruthenium today can be divided into three different areas.23 1. Electronics: 
The main application of Ru is in the hard disk drive (HDD) industry. By adding a thin layer of 
the metal to the magnetic coating of a hard disk, the data storage density is increased 
substantially. 2. Alloys: Ru is commonly alloyed with other PGMs like Pd and Pt in jewellery, 
but it also works exceptionally well with titanium. By adding 0.1% of ruthenium to titanium, 
the corrosion resistance is enhanced a hundredfold, and this property is for example utilized in 
electrodes for the electrolytic production of chlorine gas. 3. Chemicals: Ruthenium has 
become a useful metal in catalysis, and can for example be used to remove hydrogen sulfide 
from oil refineries to make sulfur-free fuels, as well as to remove ammonia from natural gas 
and acetic acid from methanol.       
 
2.2 Stability and reactivity of ruthenium complexes 
Ruthenium is the 44th element in the periodic table, has seven naturally occurring isotopes and 
exhibits the electron configuration [Kr]4d75s1. This electron configuration enables the 
formation of many different ruthenium complexes in a broad range of oxidation states, 
ranging from -II ([Ru(CO)4]2-) to +VIII (RuO4), where +II and +III are the most commonly 
observed. Ruthenium is one of the few elements together with Os, Xe, and Ir  that can form 
complexes in its +VIII oxidation state.24 Almost all ruthenium complexes are in some way 
derived from RuCl3,25-27 which in itself can be prepared in two different ways. Evaporation of 
a solution of RuO4 in aqueous hydrochloric acid under a stream of HCl gas produces red 
RuCl3·3H2O. Anhydrous RuCl3 is prepared by heating powdered ruthenium metal at 330 °C 
in carbon monoxide and chlorine, yielding the dark-brown β-form, which if heated above 450 
°C in Cl2(g) is converted to the black α-form.21 
By coordination of ligands, ruthenium can form many different and useful complexes. Two 
systems have been developed for the classification of ligands in transition metal 
organometallic chemistry, and the choice of system is a matter of preference. In the first 
system, ligands are assigned to be neutral or charged. In the second system, all ligands are 
considered to be neutral. In the latter case, some ligands donate two electrons and have been 
termed “L-type” ligands, and other ligands donate one electron to the metal center and are 
called “X-type” ligands. Ligands that donate more than two electrons have been named LX 
ligands (three electrons), L2 ligands (four electrons), L2X (five electrons), etc.28    
When it comes to stability or reactivity of various ruthenium complexes, there are several key 
factors affecting the metal-ligand bond strength. The spectrochemical series used in ligand 
field theory is more or less a measure of the σ-donor strength plus the π-donor and acceptor 
strength (back bonding), and can give an estimated bond strength. However, other factors 
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such as the chelate effect, the trans effect (kinetic) and trans influence (thermodynamic), will 
have a large influence of the metal-ligand bond strength and will also effect the rate of ligand 
substitution.28 
 
2.3 Reactive ruthenium complexes in organic synthesis 
Many ruthenium complexes possess a number of properties that make them suitable as 
catalysts in organic synthesis. Ruthenium complexes containing ligands such as carbonyls, 
halides, phosphines, pyridinyl, aminoalcohols, cyclopentadienyl, dienes and carbenes, have 
proven to serve effectively as the activating factors for generation of coordinatively 
unsaturated species by the dissociation of ligands, and/or stabilization of reactive 
intermediates. Moreover, ruthenium complexes also exhibit a variety of useful properties, 
such as low redox potential, high electron transfer ability, high ability to coordinate 
heteroatoms, Lewis acid acidity, unique reactivity of metallic species and intermediates 
including oxo-metals, metallacycles, and metal carbene complexes.29 Therefore, scientists 
around the world have been able to develop a broad range of useful reactions by applying 
catalytic amounts of various ruthenium complexes.29-51 The field of ruthenium catalysis is too 
large to cover completely or to discuss in detail, but in order to illustrate the broad scope of 
complexes and applications in catalytic reactions, some selected examples of catalytically 
active ruthenium complexes are shown in Figure 12.  
Examples of ruthenium catalyzed reactions include hydrogenation, transfer hydrogenation, 
oxidation of alcohols, alkenes and amines, water oxidation, and hydrogen autotransfer 
reactions. Moreover, C-C bond formation via ruthenacycle intermediates and via π-
allylruthenium intermediates, as well as reductive amination of allylic alcohols, ring closing 
metathesis (RCM) and cross metathesis (CM) have become very popular tools in organic 
synthesis. Development of cyclopropanation, nucleophilic addition to alkynes, and 
hydrosilylation also utilizes various Ru-complexes as catalysts. Even further, C-H activation 
(sp, sp2, sp3), C-halogen bond activation, cycloaddition reactions, reduction of CO2, 
isomerization, and racemisation of secondary alcohols are also popular transformations using 
Ru-complexes. Some selected examples from the literature are shown in Figure 13, 
employing the Ru-complexes shown in Figure 12. The use of various [RuCp*Cl]-complexes 
as catalysts in alkyne-azide 1,3-cycloaddition, i.e. the RuAAC reaction, will be discussed in 
more detail in Chapters 3, 5 and 6.  
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Figure 12. Various examples of catalytically active Ru-complexes used in organic synthesis (Cyp = cyclopentyl). 
13 
 
 
Figure 13. Some diverse examples of chemical transformations achieved by Ru-catalysis. Regiospecific 
borylation of methyl C-H bond by Ru-complex 3.39 Asymmetric cyclopropanation by Ru-complex 4.52 
Asymmetric transfer hydrogenation by Ru-complex 5.53 Aerobic dehydrogenation of amines by Ru-complex 6.54 
Ring-closing metathesis by Ru-complex 7.55 Addition of hydrazines to terminal alkynes catalyzed by Ru-
complex 8.56 Metal- and enzyme-catalyzed dynamic kinetic resolution by Ru-complex 9.57-58 Selective alkylation 
of amines with alcohols catalyzed by Ru-complex 10.59 Redox isomerisation of propargyl alcohols by Ru-
complex 11.60 sp2-C-H activated carbonylation catalyzed by Ru-complex 12.61-62 Propargylic substitution 
catalyzed by Ru-complex 13.63-71 Amide formation catalyzed by Ru-complex 14.72 
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2.4 Stable ruthenium complexes as probes and single electron transfer catalysts 
Ruthenium complexes containing stable bidentate ligands such as 2,2’-bipyridine (bpy) can 
form very stable octahedral complexes like [Ru(bpy)3]2+ (Figure 14), which exhibit interesting 
and useful photochemical properties, and are not suitable as catalysts in chemical 
transformations in the same sense as the ones shown in Figure 12. Nevertheless, [Ru(bpy)3]2+ 
has become very popular as a sensitizers in photoredox catalysis.73 [Ru(bpy)3]2+ absorbs light 
in the visible region (452 nm) of the electromagnetic spectrum to give stable, long-lived 
photoexcited states (τ = 1100 ns).74 The lifetime of the excited species is sufficiently long that 
it may participate in bimolecular electron-transfer reactions in competition with deactivation 
pathways,75 as well as a being an efficient single electron transfer (SET) catalyst.76  
 
Figure 14. The structure of [Ru(bpy)3]2+. 
These properties of Ru-complexes such as [Ru(bpy)3]2+ have made them an interesting and 
useful tool as fluorescent probes in physical chemistry, in many different contexts. By varying 
the ligands on ruthenium, the emission properties of a Ru-complex can be fine-tuned.77-80 The 
complexes becomes even more useful as probes when one of the ligands is replaced by a 
dipyrido[3,2-a:2',3'-c]phenazine (dppz) ligand, which makes their luminescent properties very 
sensitive towards the environment. The complexes [Ru(phen)2dppz]2+ and [Ru(bpy)2dppz]2+, 
shown in Figure 15, are called light-switching complexes due to the fact that they are brightly 
luminescent upon intercalation into DNA, while in water the excited states are almost 
completely quenched by water H-bonding to the dppz’s phenazine nitrogens.81-83 
 
Figure 15. The light-switch complexes [Ru(phen)2dppz]2+ and [Ru(bpy)2dppz]2+. 
The long-lived excited states of these Ru-probes also makes them vital tools for studying 
dynamics and rotational motions of biological molecules.84 In 1984, Barton et al. reported a 
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DNA-binding study of [Ru(phen)3]2+, which was an important milestone for the field of 
ruthenium-based DNA-probes. 85 Since then, several examples of ruthenium complexes that 
selectively bind to different DNA and RNA bulge structures,86 compact DNA,87-88 display 
cytotoxic activity,89-90 or stain various cellular components, 91-93 have been studied with the 
hope for potential applications as diagnostic probes, anti-cancer drugs, imaging agents or gene 
delivery vectors. The use of binuclear ruthenium complexes as DNA threading intercalators 
will be discussed later in this thesis in Chapter 7, together with synthesis of new binuclear 
ruthenium complexes.  
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3 1,3-Dipolar Cycloadditions as a Route to Nitrogen Heterocycles  
 
 
3.1 1,3-Dipoles 
There are many ways to synthesize nitrogen heterocycles, including ring closure, ring 
expansion, condensation, and cycloaddition reactions. From now on we will focus on 1,3-
dipolar cycloadditions as a route to form 5-membered nitrogen heterocycles.  
The work done by Curtius in 1883, when he reported the first synthesis of diazoacetic esters,94 
enabled the first 1,3-dipolar cycloadditions between diazoacetic esters with α,β-unsaturated 
esters, to be carried out by Buchner et al. a few years later. 95 In 1963 Huisgen et al. published 
a systematic study on concerted 1,3-dipolar cycloadditions,96 based on previous work by 
Smith and co-workers,97 including also kinetic studies on the mechanism.98 The reaction 
between a highly polarized 1,3-dipole (a-b-c) and a dipolarophile (d-e), i.e. a double or triple 
bond, is often called a 1,3-dipolar cycloaddition, shown in Figure 16. 
 
Figure 16. Two types of dipoles, allyl- and propargyl anion type, are used in 1,3-dipolar cycloadditions. 
 
However, the formal name is a [3+2] cycloaddition, and this reaction leads to a remarkably 
wide variety of 5-membered heterocyclic compounds. The classification of the most common 
1,3-dipoles are outlined in Figure 17.99-100  
Besides the concerted mechanism of 1,3-dipolar cycloadditions reported by Husigen, a 
stepwise mechanism via a singlet diradical intermediate has been proposed.101 In a 
computational study of the 1,3-cycloaddition between nitrones and alkenes, Di Valentin et al. 
found that the concerted mechanism should be much more favourable than the stepwise 
diradical mechanism.102-103 To date, the Husigen 1,3-dipolar cycloaddition is described as 
nonconcerted when catalysts, proceeding via metallacycle intermediates, are used, leading to 
substituted heterocycles in excellent selectivity.104  
a
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Figure 17. The classification of the most common 1,3-dipoles. 
The understanding of the reactivity and regioselectivity of 1,3-dipolar cycloadditions is not 
always straightforward. However, frontier molecular orbitals (FMO) theory has shown to be a 
first approximation to a perturbation treatment of chemical reactivity and has been used to 
predict/explain the regioselectivity of several 1,3-dipolar cycloadditions105-110 As an example, 
the thermal 1,3-dipolar azide-alkyne cycloaddition will result in a mixture of the two 
regioisomers (1,4- and 1,5-). By choosing the appropriate catalyst, the regiochemistry can be 
controlled and this will be described in more detail in the following chapters.   
This thesis will focus on the 1,3-dipolar cycloaddition as a route to form 5-membered nitrogen 
heterocycles, more specifically, pyrrolidines and 1,2,3-triazoles (highlighted in Figure 6). 
Azides were used as dipoles in paper I and an azomethine ylide was used in paper IV. 
 
3.2 CuAAC 
The Huisgen reaction between azides and alkynes is very slow in the formation of triazoles at 
room temperature, and at higher temperatures the triazoles are formed as mixtures of the 1,4- 
and 1,5-regioisomer. Due to the superb independent discovery of the Cu(I)-catalyzed azide-
alkyne 1,3-dipolar cycloaddition, also known as CuAAC,111-112 in 2002 by both Meldal113 and 
Sharpless,114 1,4-disubstituted 1,2,3-triazoles can now be obtained in excellent yield and 
regioselectivity (Figure 18). Not only does the Cu(I) catalyst control the selectivity, yielding 
only the 1,4-isomer of the product, but it also increases the reaction rate by approximately 107 
times, and enables performance in aqueous media. The CuAAC reation offers several 
supplementary advantages that are characteristic of “Click Chemistry”, an expression coined 
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by Sharpless et al.115 The definition of the term “Click Chemistry” is as follows: “The 
reaction must be modular, wide in scope, give very high yields, generate only inoffensive 
byproducts that can be removed by nonchromatographic methods, and be stereospecific (but 
not necessarily enantioselective). The required process characteristics include simple 
reaction conditions (ideally, the process should be insensitive to oxygen and water), readily 
available starting materials and reagents, the use of no solvent or a solvent that is benign 
(such as water) or easily removed, and simple product isolation. Purification - if required - 
must be by nonchromatographic methods, such as crystallization or distillation, and the 
product must be stable under physiological conditions.” Today the CuAAC reaction is the 
most commonly used 1,3-dipolar cycloaddition reaction in organic synthesis.116  
 
 
Figure 18. Control of the regiochemistry in azide-alkyne 1,3-dipolar cycloaddition. 
The active copper species in the CuAAC reaction is Cu(I), but both Cu(0) and Cu(II) may be 
used as well. Most frequently, Cu(II)-salts are selected as an appropriate copper source, since 
they can easily be reduced in situ to Cu(I) in the presence of a reducing agent. Sodium 
ascorbate is the most commonly used reducing agent for Cu(II)-salts when the CuAAC 
reaction is performed in an aqueous media.114,118-120 In order to ensure that all Cu(II) has been 
reduced to Cu(I) and remains as Cu(I) during the reaction, an excess of the reducing agent is 
required. The direct use of Cu(I)-salts is less frequent, due to the instability of the Cu(I)-
species under aerobic conditions. To prevent oxidation of the active catalyst, the CuAAC 
reaction needs to be performed under anaerobic conditions or a stabilizing ligand can be 
added. A number of ligands that have been used to stabilize the Cu(I)-species are shown in 
Figure 15. Several of these ligands are known to increase the life time of the Cu(I)-species, 
thereby allowing reactions to be performed under air. The most well-known stabilizing ligand 
is the tris((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)amine (TBTA) ligand 15 investigated by 
Fokin et al. 121 Not only do the ligands 15 – 26 (shown in Figure 19) protect the active Cu(I)-
species under aerobic reaction conditions, they also accelerate the rate of triazole formation. 
Beside the rather complex amine ligands in Figure 19, the use of more common bases like, 
pyridine124 and lutidine125 and also amino acids like proline126-128 and histidine129-130 have been 
studied as rate accelerating additives.  
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Figure 19. Structure of several ligands which have been used to stabilize Cu(I)-species. 
Today the two most active catalysts for the CuAAC reaction are the Cu(I)-TBTA 
complex118,131-133 and the Cu(I)-bathophenanthrolinedisulfonic acid complex.129,134-137 The use 
of [Cu(CH3CN)4]PF6,114 [Cu(CH3CN)4]BF4117 and [Cu(PPh3)3]Br122-123 have been shown to 
enhance solubility in non-aqueous systems as compared to the normal CuBr and CuI salts. 
Moreover, Cu(I)-species have been loaded onto solid supports,138,139 zeolites140,141 and Al2O3 
nanoparticles.142 Cu(0) can also catalyze the CuAAC reaction indirectly via the formation of 
Cu(I) by comproportionation of  Cu(II) and Cu(0). The essential Cu(II)-species can be added, 
but is not mandatory due to the presence of traces of copper oxides and carbonates on the 
metal surface. However the disadvantage of this procedure is that it suffers from long reaction 
times.   
Despite several mechanistic investigations and computational studies, the proposed 
mechanism of the CuAAC reaction outlined in Figure 20 has not yet been completely proven. 
114, 116, 118, 143-146 Some details, especially those concerning the complexation of the Cu(I)-
species and the origin of selectivity of the cycloaddition, are still unknown. 
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Figure 20. Proposed mechanism for CuAAC reaction.116 
 
3.3 RuAAC 
Selective formation of 1,5-disubstituted 1,2,3-triazoles can today also be achieved by the use 
of a ruthenium catalyst in the so called RuAAC reaction (Figure 18), first reported in 2005 by 
Fokin in collaboration with Jia.147 In contrast to the CuAAC reaction, the RuAAC reaction 
also works well on internal alkynes, giving rise to trisubstituted 1,2,3-triazoles. The selectivity 
of unsymmetrical internal alkynes has been studied by Majireck and Weinreb.148 Since the 
first report on the RuAAC reaction, a few studies on the scope and reaction mechanism have 
been carried out,149-151 and the RuAAC reaction has been used in various applications,152-155 
but to a far lesser extent compared to the popular CuAAC reaction. The reason is probably 
due to lower tolerance towards functional groups on any of the substrates and sterical 
hindrance on the azide, as well as limitations in terms of the solvents that can be used. 
The active species of the ruthenium catalyst seems to be [RuCp*Cl] and a number of 
complexes with different ligands have shown good activity and selectivity. Many results point 
toward the Cp* ligand (pentamethylcyclpentadiene anion) as the key element in the catalyst 
responsible for the high 1,5-selectivity. The mechanism for the RuAAC reaction has been 
studied by theoretical calculations, and the proposal by Fokin and Jia is outlined in Figure 
21,150 and a recent proposal from the Nolan group is shown in Figure 22.151 The electronic 
effects on internal alkynes have been studied by Hou et al.156 and recently an interesting 
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method to assign the regiochemistry of 1,2,3-triazoles by 13C NMR has also been reported by 
Creary et al.157  
 
Figure 21. Mechanism for the RuAAC reaction proposed by Fokin. L = PPh3 or 2 L = COD.150 
 
Figure 22. Mechanism for the RuAAC reaction proposed by Nolan.151 
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3.4 Azomethine ylide cyclizations  
Another 1,3-dipolar cycloaddition is the one between azomethine ylides and activated double 
bonds, forming pyrrolidines. One example is the solvent free microwave-assisted [3+2] 
cycloaddition of stabilized azomethine ylides 27 with nitrostyrenes 28, leading to the 
sterioisomeric 4-nitropyrrolidines 29 in 79-87% yield, reported by Arrieta et al. and shown in 
Figure 23.158 The azomethine ylide in this reaction is a resonance form of the imine, stabilized 
by the ester group. 
 
Figure 23. 1,3-Dipolar cycloaddition of azomethine ylides with nitro styrenes. 
Azomethine ylides have also been used in the synthesis of C(2)-unsubstituted penems, in the 
form of β-lactam-based azomethine ylide 31. Thermolysis of β-lactam 30 by microwave 
heating in toluene led to azomethine ylide 31 and in situ cycloaddition with S-methyl 
dithioformate yielded the thiazolidine 32 in 76%.159,160 Subsequent mild oxidation and base 
treatment affords the C(2)-unsubstituted penem 33, as shown in Figure 24.   
 
Figure 24. Azomethine ylide formation by thermolysis of β-lactam 30. 
More importantly from our point of view is the broad number of reports on the 1,3-dipolar 
cycloaddition of azomethine ylides to C60, first described by Prato,161 and also to carbon 
nanotubes (CNTs) in solution.162-172 An example where the azomethine ylides are generated 
by decarboxylation of iminium ions derived from the condensation of amino acids with  
aldehydes affording fulleropyrrolidines 34, is shown in Figure 25. 
24 
 
 
Figure 25. 1,3-Dipolar cycloaddition of azomethine ylides to C60. 
Worth to mention is that the functionalized CNTs can also be converted back to unmodified 
CNT upon heating to above 350 °C, as reported by Prato and Ballerini.173,174 This technique is 
often used to purify CNTs.    
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4 Peptidomimetic Foldamers 
 
 
4.1 Foldamers 
A foldamer is a non-natural folded peptidomimetic oligomer. 
Over the last two decades, non-natural biocompounds, with structure and function mimicking 
the natural biocompunds, have attained exceptionally increased scientific attention due to 
their potential applicability in diverse areas such as chemical biology, pharmacology, or 
bionanotechnology. The most successful advances in the future are anticipated in areas where 
the synthetic compounds are capable of retaining the beneficial characteristics of natural 
molecules, while showing significant enhancement in other properties where the latter have 
limitations. As such an example, the study of foldamers has become a separate field.175-178 
The term foldamer as defined by DeGrado:  
“Foldamers are sequence-specific oligomers akin to peptides, proteins and oligonucleotides 
that fold into well-defined three-dimensional structures” 
Because of the diversity of sizes, shapes and properties available to non-natural monomers, 
this field offers a myriad of opportunities for the design of molecular interaction modules 
supported by foldamer scaffolds. The creation of these scaffolds has already resulted in many 
useful and functionally interesting foldamers, capable of mediating cell penetration,179-180 and 
showing advantageous qualities such as enzyme resistance,181 antitumor,182 antiviral, 
antifungal and antibacterial activity.183-193 Moreover, designed foldamers with specific 
binding to various targets, including proteins,194-201 RNA,202 DNA,182, 203-204 membranes,205-214 
and carbohydrates215 have also been reported. Often these foldamers show affinities matching 
or even outperforming those of natural α-peptides. 
 
4.2 Foldamer classes and structures of monomers 
Foldamers can generally be divided into two classes, aliphatic foldamers and aromatic 
foldamers, depending on if the amine and acid functional group of the monomer is interrupted 
by an aromatic unit or not. Aliphatic foldamers can for example consist of α-,195, 216 β-,217-219 
γ-220-222 or δ-amino acids,223-224 oligoureas,225 or azapeptides.226-227 Some examples of a few 
common frameworks are shown in Figure 26.  
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Figure 26. Examples of foldamer frameworks 
 
4.3 Secondary structures of foldamers 
When foldamer monomers are combined into homo-oligomers or hetero-oligomers, they 
exhibit an affinity to fold into different secondary structures depending on the type of residue, 
sequence, chirality, and substituents. These secondary structures are stabilized by non-
covalent intramolecular interactions, most often hydrogen bonds (H-bonds), and give rise to 
different conformers. Their nomenclature is commonly based on the size of the pseudo-ring 
formed by the intramolecular interaction and on the type of the resulting secondary structure. 
In Figure 27 some of the simplest conformers of β-peptides are shown. Here C stands for 
conformer, H for helix and the number denotes the number of atoms in the intramolecular H-
bond pseudo-ring. Predictions by ab initio MO theory177 of short sequences of unsubstituted 
β-alanine have shown that C6 and C8 oligomers are favoured by the backbone, and also as the 
sequence is increased, structures such as H10 and H12 are favoured internally by cooperative 
effects. In contrast, these calculations also suggest that for non-cyclic peptide backbones the 
H14 is disadvantaged, however polar solvents and appropriate sequences will greatly stabilize 
it, making it one of the most commonly observed helices experimentally. This shows the 
important influence of the chemical environment (the solvent) on the stability of the different 
conformers. 
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Figure 27. Oligomers of β-peptides can adopt several conformational structures, such as C6-ribbon, C8, H10, H12 
and H14. 
In order to stabilize a preferred secondary structure from all the possible conformers, suitable 
substituents can be introduced at specific positions with the appropriate chirality on the 
monomer.218, 219, 229-231 Recent work has further extended the concept of stabilizing secondary 
structures with cyclic side-chain topology. De Pol et al. have reported helix-like foldamers 
built up from β-amino cyclopropanecarboxylic acids.231 Likewise, Izquierdo et al. observed a 
14-membered H-bonded ring for a tetramer containing two cis-aminocyclobutanecarboxylic 
acid (cis-ACBC) residues and two β-alanines in alteration, indicating the tendency of the 
ACBC unit to fold.232 If the cis-ACBC is elongated into homo-oligomers, they exhibit strand-
like structures that are stabilized by 6-membered intramolecular H-bonds, which facilitate 
supramolecular interactions and self-assembly, producing nanosized fibres or gels.233-235 
However, by switching to the trans-ACBC residue, hexamers and octamers demonstrate a 
preference to fold into well-defined H12-helical conformers, both in solution and in the solid 
state.236  
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Not only can a foldamer form different helix structures depending on the H-bond ring-sizes, 
but also chiral left-handed (M) and right-handed (P) helixes. If a foldamer backbone is 
achiral, both the M and P helices will be present and most probably also be in fast equilibrium 
with each other (Figure 28.). By introducing chiral residues in a foldamer sequence, the 
equilibrium will shift and the framework will favour either the M-helix or the P-helix 
structure.  
 
Figure 28. M- and P-helixes in equilibrium.  
The Clayden group have made some very interesting foldamer research where they 
investigated how far information can be transferred by conformational changes.237-241 They 
used amino-iso-butyric acid (Aib) as the monomer to synthesize long oligomers. Oligomers of 
Aib adopt stable H-bonded helical structures, usually H10, with a low barrier to inversion 
between the enantiomeric M- and P-forms. By attaching a switchable reporter unit (3-
phenyllactate) in one end and a receiver unit (13C-labelled Aib helicity detector) in the other 
end, they have demonstrated conformational communication through the helices up to 12-
residues of Aib by using 13C NMR to read the output signal.242 Figure 29 shows the schematic 
structure of Claydens switchable foldamer helix.  
 
Figure 29. Clayden’s switchable Aib foldamer, capped by a 3-phenyllactate controller and a 13C-labelled Aib 
detector.242 Dashed arrows shows interresidual H-bonds, responsible for the formation of the H10-helical 
secondary structure. 
By hydrolysis of the benzoate ester and inversion of the stereochemistry of the alcohol via the 
Mitsunobu reaction,243-245 the readout in terms of the intensity of the 13C-shifts for the methyl-
groups on the end Aib-receiver was inverted. This result proves that the switchable chirality 
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on the controller unit determines the favoured chirality of the foldamer helix, which is 
transferred all the way through to the detector unit.  
 
4.4 Triazoles in peptidomimetics and foldamers  
The triazole unit, both in the form of the 1,4- and the 1,5-regioisomer, has become a popular 
building block in peptidomimetics over the last 10 years.246-247 This is mainly because  their 
structural and electronic characteristics are similar to those of a peptide bond, but also because 
general synthesic methods are now available via the CuAAC113-115, 248 and the RuAAC147-150, 
249 reactions, both described in more detail in Chapter 3. 1,4- and 1,5-triazoles are good 
analogues of peptide bonds because they are planar, while at the same time possessing a 
strong dipole and H-bond properties that mimic those of a peptide bond. The 1,4-substituted 
triazole is a fine mimic of a common trans-peptide bond, even though it will give rise to 
slightly longer distances between the side chains, as seen in Figure 30. The 1,5-triazole on the 
other hand is a good mimic of the usually more unfavoured cis-peptide bond, which enables 
turn- and bent-peptidomimetic structures.  
 
Figure 30. Comparison of 1,4-substituted triazoles with trans-peptide bonds and 1,5-substituted triazoles with 
cis-peptide bonds. 
One of the greatest advantages with triazoles is that, unlike peptide bonds, they are 
proteolytically and metabolically stable. In addition, the azide and the alkyne precursors are 
relatively inert, enabling in vitro CuAAC reactions.250-251 More recent development of the 
Huisgen cycloaddition of strained cyclic alkynes with azides,252-253 has facilitated selective in 
vivo labelling of biomolecules in live mice.254    
The 1,4-substituted triazole has been utilized to a great extent, both in linear and cyclic 
peptidomimetics,255 as well as, in a few short oligomers, with and without intercepting peptide 
bonds.256-260 Improved CuAAC reaction conditions, where the ratio between intramolecular 
cyclization and linear dimerization was increased, have been reported by Chouhan and 
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James.261 The 1,5-substituted triazole, unit on the other hand, has not been exploited as much 
as the 1,4-isomer in the field of peptidomimetics. However, a few very interesting 
applications have been reported including their use in constrained histidine mimics,262 in 
cyclic Vancomycin-inspired peptidomimetics,263 as cis-peptide bond surrogates in RNase A 
variants from bovine pancreas and Escherichia coli264 and in the peptoid oligomer 35 to 
induce turn formation,265 which is shown in Figure 31.     
 
Figure 31. Incorporation of the 1,5-substituted triazole in a peptoid turn.  
This leaves the foldamer field open for opportunities to investigate oligomers consisting of 
1,5-substituted triazoles. Our initial results in this area will be presented in Chapter 6.  
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5 Ruthenium Catalyzed Azide-Alkyne 1,3-Dipolar Cycloadditions  
 
 
5.1 Aim of the project 
When we started to work with the RuAAC reaction, our aim was to develop a one-pot 
procedure where the hazardous organic azide is generated in situ. Such a procedure would be 
more simple and safe to use for the synthetic chemist since no isolation and handling of the 
neat organic azide would be needed. A convenient one-pot procedure has been reported for 
the CuAAC reaction127 and our main goal for this project was to develop a similar method for 
the RuAAC reaction that would hopefully increase the use of the reaction.  
 
5.2 Results 
To begin our study, we started by reproducing the method from the literature, with our model 
reaction between 3-ethynyl pyridine and benzylazide, catalyzed by [RuClCp*(PPh3)2]. After 
heating the reaction mixture to 60 °C for 6 h in dioxane, 3-(1-benzyl-1H-1,2,3-triazol-5-
yl)pyridine 36 was obtained in 92% yield after purification on silica. We also ran the reaction 
using microwave heating for 30 min at 100 °C, and this method gave similar results.  We 
continued our study by reinvestigating in which polar solvents the RuAAC reaction can be 
performed and by varying the ratio between the azide and the alkyne. The results from the 
solvent investigation are shown in Table 1. 
 
 
Table 1. RuAAC reaction to form triazole 36 with an alkyne/azide 
ratio of 1:1 in different solvents (conv. estimated by LCMS). 
 
Solvent Conv. Solvent Conv. Solvent Conv. 
Dioxane ~95% DMA ~95% H2O ~5% 
THF 100% DMSO <5% THF/H2O 3:1 ~10% 
2-MeTHF 100% CH3CN ~5% CH3CN/H2O 3:1 ~5% 
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Apart from the good conversions obtained for the RuAAC reactions in dioxane, toluene and 
THF, DMA as well as 2-MeTHF also gave satisfying results. In contrast, the use of DMSO or 
ACN as the solvent gave only traces of product in the reaction. The use of water or other 
protic solvents such as ethanol, as well as mixtures of polar solvents with water, lead only to 
very low yields of the desired 1,5-disubstituted 1,2,3-triazole. Dimerization of the alkyne was 
found as the major by-product of the reaction,266 albeit in small amounts (only a few %). The 
formation of the enyne by-product 38 could be suppressed to a minimum by employing two 
equivalents of the azide, but increased when an excess of the alkyne was used. Fokin et al. 
reported the formation of a stable catalytically inactive “azide dimerization - catalyst 
complex” 37 inhibiting the RuAAC reaction when an excess of azide was used, or when the 
azide was added to the catalyst prior to the alkyne.75 However, in our system we could never 
detect (by LCMS or 1H NMR on the crude reaction mixture) this complex during our 
reactions, even though two equivalents of the azide were used. Figure 32 shows the structure 
of these two possible by-products.   
 
 
Figure 32. Possible by-products in the RuAAC reaction. 
With the reaction conditions tuned, we turned our attention to developing a one-pot 
procedure. We wanted to investigate the possibility of using sodium azide in combination 
with an alkyl halide to generate the organic azide in situ, and to let this azide react directly in 
the RuAAC reaction without the need for isolation.  Since the synthesis of organic azides 
from sodium azide and halides is usually performed in a polar solvent like DMSO, water or 
DMF (or mixtures thereof), the obvious choice for a one-pot procedure is DMF or DMA 
according to the results of the solvent screening. DMF has a lower boiling point than DMA 
and is thus easier to evaporate after the reaction, but it is also more toxic and starts to 
decompose when heated in a microwave above 130-140 °C. These properties lead to our 
choice of DMA as the solvent for a potential one-pot procedure. However, initial studies of a 
direct one-pot procedure were unsuccessful. Only traces of the triazole product was seen, and 
substantial amounts of starting materials remained unreacted. We believe that this procedure 
fails due to a side reaction of sodium azide with the catalyst. By substitution of the chloride 
with the nucleophilic azide anion an inactive catalyst complex 39 can be formed as shown in 
Figure 33.267  
 
Figure 33. Possible deactivation of the [RuClCp*L2] catalyst by sodium azide.  
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By simply changing the procedure into a sequential one-pot reaction, the 1,5-disubstituted 
1H-1,2,3-triazole 36 (Table 3, entry 4) was successfully obtained, as shown generically in 
Figure 34. The key message is to avoid an excess of sodium azide in order for the sequential 
method to be successful. 
 
 
Figure 34. Sequential one-pot RuAAC reaction. 
 
With a practically simple and rather safe sequential one-pot procedure in hand, we wanted to 
investigate the scope of the reaction and the tolerance to different functional groups in the 
azide as well as alkyne substrates. A broad range of different substrates were tested and the 
results are summarized in Tables 2-5. As can be seen in Table 2, small volatile halides such as 
iodomethane, allyl chloride and 2-bromoethanol gave unsatisfying yields. The question 
whether they fail to produce the triazoles products due to the low boiling point of the halide 
and/or azide formed, or due to the instability and possible decomposition of the small labile 
azides, or because there is a problem with sodium azide poisoning the catalyst due to an 
uncompleted substitution reaction remains unanswered. Secondary bromides such as 
bromocyclohexane gave no triazole formation at all in our sequential procedure. However, it 
has been demonstrated with several examples in the literature that secondary azides do react 
in the RuAAC reaction, although they require longer reaction times and sometimes also high 
temperatures. It is thus more likely that there is a problem in the formation of the cyclohexyl 
azide, also since bromocyclohexane is known to be a poor substrate for SN2-reactions, and 
can undergo an elimination reaction to form cyclohexene instead. It would be interesting to 
test the sequential procedure on a benzylic secondary bromide such as (1-bromoethyl)benzene 
or similar to see if such substrates reacts.   
 
Primary bromides on the other hand work very well, and a number of examples are shown in 
Table 3. Among the number of functional groups tolerated in the sequential one-pot procedure 
are: ester, amide (or imide), Boc protected amine, alchohol, sulphide, chloride and basic 
heterocycles such as pyridine and imidazole. Activated bromides, both benzylic (Table 3, 
entries 2-5), and in the form of an α-bromo ester (Table 3, entry 1) react smoothly and afford 
the triazole product in 82-93% yields. 
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Table 2. Sequential one-pot RuAAC reaction using small volatile halides and secondary halides. A = 
[RuClCp*(PPh3)2] and B = [RuClCp*]4. 
 
 
 
Alkyl bromides also work well but seem to react more slowly, leading to a slightly lower 
yield i.e. ~70% (Table 3, entries 6 and 8). However, by increasing the temperature from 80 °C 
to 100 °C for the substitution reaction, and from 100 °C to 120 °C for the cycloaddition, an 
excellent yield was obtained (Table 3, entry 9).   
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Table 3. Sequential one-pot RuAAC reaction using primary bromides and [RuClCp*(PPh3)2]. 
 
 
 
Interestingly we found that any substrate in the form of a HCl- or HBr-salt or containing a 
carboxylic acid were unsuccessful in the formation of triazole product. Some examples are 
shown in Table 4. We draw the conclusion that the active [RuClCp*] complex is sensitive 
towards acidic protons. Moreover, primary chlorides also form the 1,5-disubstituted 1,2,3-
triazoles in acceptable to excellent yields, and a few examples are shown in Table 5.     
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Table 4. Sequential one-pot RuAAC reaction using substrates containing HCl-salts or carboxylic acids. A 
= [RuClCp*(PPh3)2] and C = [RuCl2Cp*]x. 
 
 
 
Worth to mention is also that alkyl chlorides as well as the aliphatic bromides benefit from 
higher reaction temperatures. Interestingly, fluoride substituents are also acceptable on both 
the halide and the alkyne substrates. In addition to the [RuClCp*(PPh3)2] catalyst, we also 
tested a Ru(III) complex, [RuCl2Cp*]x, which surprisingly also showed excellent activity in 
the sequential one-pot procedure. Preliminary results even point towards higher isolated 
yields compared to the [RuClCp*(PPh3)2] catalyst, as shown in Table 6.  
 
Table 5. Sequential one-pot RuAAC reaction using primary chlorides. 
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Table 6. Sequential one-pot RuAAC reaction using [RuCl2Cp*]x as catalyst. 
 
However, when looking into the literature in more detail it was found that both Fokin75 and 
Qing268 had already observed good yields with this catalyst as well. 
In order to verify the 1,5-regioselectivity of the 1,2,3-triazoles produced, we performed 2D 
NOESY experiments on triazole 40 and 41 in Table 3. The 1,4-regioisomer of triazoles 40 
would not give rise to any NOE-cross peak between HA and HB, which is the key NOE for the 
1,5-regioisomer, shown in Figure 35. The triazole proton HC gives a NOE cross-peak to HB 
for the 1,5-isomer, but for the 1,4-isomer it should give rise to cross-peaks to both HA and HB.  
As can be seen in the 2D NOESY spectra in Figure 37, a clear NOE cross-peak between HA 
and HB can be seen which proves the 1,5-regioisomer structure. Further, the HC proton lacks 
any NOE-cross peak to HA, which also supports the structure assignment. Figure 36 shows the 
expected NOE’s for proton HA and HB in the 1,5-regioisomer. All 4 NOE’s for HA and all 5 
NOE’s for HB could be assigned in the 2D NOESY spectra in Figure 37. The 1,5-
disubstitution pattern was successfully confirmed by the 2D NOESY experiment. 
 
Figure 35. The key NOE for the 1,5-regioisomer of triazole 40 is between HA and HB which is absent in the 1,4-
regioisomer. Also, a NOE cross-peak for HA and HC is present in the 1,4-regioisomer, but absent in the 1,5-
regioisomer. 
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Figure 36. Four expected NOE’s for protons HA and five for HB in triazole 40.  
 
Figure 37. 2D NOESY spectra on 28 mg of triazole 40 (in Table 3) in DMSO-d6. The spectrum was recorded at 
25 °C using a mixing time of 700 ms, delay time of 3 s, np = 4096 (f2), ni = 512 (f1) and nt = 8.   
 
The 2D NOESY experiment of triazole 41 (in Table 3) also confirmed the 1,5-regioisomer 
structure. Although the quality of the spectra was not as good as for triazole 40 (in Table 3) 
and all expected NOE’s were not assigned, the key NOE between HA and HB (α-azide and α-
alkyne) was identified. 
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5.3 Summary  
A safe and experimentally simple sequential one-pot procedure for the RuAAC reaction, 
starting from alkyl halides has been developed. This procedure avoids handling of the 
hazardous neat alkyl azides and forms the 1,5-regioisomer in good to excellent yields. The 
scope of the reaction is broad, and functional groups such as alcohol, ester, amide, chloride, 
carbamate, fluoride, sulfide, nitro and heterocycles such as pyridine and imidazole can be 
tolerated in the substrates. However, there are some limitations. Functional groups such as 
carboxylic acids and HCl-salts of mild bases have not been successful in the sequential one-
pot procedure. Small volatile halides have also been problematic and only low yields of the 
triazole have been obtained in a few cases. However, both primary bromides and chlorides, 
benzylic as well as aliphatic, yield the 1,5-disubstituted-1,2,3-triazoles in good yields and 
excellent regioselectivity. Moreover the [RuCl2Cp*]x was also found to be an efficient 
catalyst for the RuAAC reaction. 
5.4 Future plans  
Development of a solid supported catalyst for the RuAAC reaction would be greatly 
appreciated by synthetic chemists. We have initiated a project towards synthesis of a polymer-
bound RuAAC catalyst using a modified Cp*-ligand. Introduction of a functional group on 
the Cp*-ligand could potentially facilitate attachment to any type of solid support. However, 
recent work from the Astruc group has demonstrated the construction of a ruthenium complex 
supported on magnetic nanoparticles, having the phosphine ligands bound to the 
nanoparticle.269 The active catalyst is probably dissociated into the solution under the reaction 
conditions, keeping the homogeneous catalysis reaction rate. We envision that despite this 
first solid-supported RuAAC catalyst, there would still be of great interest to create a Cp*-
bound catalyst for the RuAAC reation, and also such a Cp*-bound ligand could easily be 
employed to anchor useful transition metal complexes for other catalytic reactions. Such a 
catalyst would greatly simplify the purification process and enable recycling and reuse of the 
catalyst. It would also be of interest to further explore the tolerance of functional groups 
present on the substrates, as well as to look further into the substrates that did not afford the 
desired product.  
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6 Synthesis and NMR-Studies of δ-Peptidomimetics  
 
 
6.1 Introduction  
Non-natural peptidomimetics is currently an exponentially growing field, owing to the great 
biomedical potential of this class of compounds as well as their self-assembling affinity, and 
high enzyme resistance.175-178,181-182,270 The key for the successful application of foldamers, 
i.e. non-natural folded peptidomimetic oligomers, is basically finding compounds which can 
reproduce some of the fundamental properties of natural peptides and proteins, such as 
structural flexibility and water solubility. Moreover, easy access to diverse amino acid units 
by robust modular synthesis also plays an important role in facilitating the construction of 
such foldamers.  
The structural and constitutional composition of most foldamers can be derived back to 
natural peptide backbones, where α-amino acids and their homologues, β-, γ-, etc. amino 
acids, are used. Since these homologues result in increased backbone flexibility, both aliphatic 
and aromatic cyclic insertions have been applied to facilitate folding into various, mainly 
helical, secondary structures.175,246,271-275 By today, many diverse examples can be found; 
however, in many cases the elongated hydrocarbon chains and the aliphatic cyclic insertions 
have raised solubility problems.246, 276-277 Accordingly, despite showing some very interesting 
potential in the field,177,276 peptide derivatives built from longer homologues, such as δ-
peptides are still rare among foldamers. Further exploration of δ-amino acid substituents is 
expected to have significant importance, as the backbone constitution of δ-amino acid 
derivatives easily fits into sequences of natural α-peptides.278 
With recent gain in knowledge of the RuAAC reaction from our previous work (paper I), we 
identified the possibility to apply this reaction towards the cis-peptide bond mimic, 2-(5-
(aminomethyl)-1H-1,2,3-triazol-1-yl)acetic acid (5Tzl) and analogues, in a convenient 
modular way. Together with Dr. Beke-Somfai’s previous experience of foldamers constructed 
from β-amino acids,279-282 as well as based on the properties of the 5Tzl monomer, and on 
preliminary conformational analysis, it was anticipated that oligomers built out of these 5Tzl 
units may have all the above key properties. Therefore, it was natural that we took the first 
steps towards exploring this field by synthesizing oligomers of the 5Tzl δ-amino acid mimic 
and investigating their structural properties and solubility. 
 
6.2 Synthesis of oligomers of 5Tzl 
The 5Tzl 42 was produced via a microwave assisted RuAAC reaction between methyl 2-
azidoacetate and N-Boc-propargylamine in THF (Figure 38). The reaction works well when 
the commonly employed [RuClCp*(PPh3)2] catalyst is used. Nevertheless, when using flash 
chromatography on silica for the purification of the crude material, we were unable to 
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separate the catalyst remaining from this particular triazole product 42, when using a gradient 
of 0-30% MeOH in CH2Cl2. Based on our previous work with the RuAAC reaction (chapter 
5), we found that a Ru(III) catalyst [RuCl2Cp*]x,147,268 could be applied with excellent results 
in this reaction.  
 
Figure 38. Synthesis of the 5Tzl monomer 42, using 4 mol% [RuCl2Cp*]x as catalyst in THF for the microwave 
assisted RuAAC reaction. 
With only 4 mol% of the [RuCl2Cp*]x catalyst in THF, the triazole 42 was obtained in 96% 
yield, in this case without the separation problems encountered with [RuClCp*(PPh3)2] for 
this particular triazole product. This is a great improvement compared to previous routes to 
similar compounds.262,265 The regiochemistry of the 1,5-disubstituted triazole 42 was 
confirmed by 2D NOESY, see Figure 39.  
 
 
Figure 39. Selected part of the 2D NOESY spectra of 42, recorded in DMSO-d6 at 25 °C using a mixing time of 
600ms. 
From the triazole monomer 42, dimer 45, trimer 48 and tetramer 49 were synthesized using 
standard deprotection and coupling methods. The Boc-group of 42 was quantitatively 
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removed by treatment with TFA in CH2Cl2. The ester hydrolysis to form acid 44 was then 
optimized, and the best results were achieved with 1M LiOH (aq) (1.5 equiv.) in MeOH at 
ambient temperature. Amide coupling of building blocks 43 and 44 using T3P®283-285 as the 
coupling agent gave dimer 45 in a moderate yield, as outlined in Figure 40.  
 
Figure 40. Synthesis of the 5Tzl-dimer 45 from 5Tzl-monomer 42, using standard deprotection conditions and 
T3P as the amide coupling reagent.   
The deprotection of 45 to amine 46 proceeded without any problems using either TFA in 
CH2Cl2 or HCl in dioxane/MeOH. The selective hydrolysis of the methyl ester of 45 to 47 
was performed at room temperature with 1M LiOH (1.5 equiv.) in MeOH and afforded 
carboxylic acid 47 in 93% yield. Trimer 48 could then be formed via coupling of dimer 46 
with monomer 44 using T3P® as the coupling reagent, though in a low yield (unoptimized) as 
outlined in Figure 41. The solubility in water of compound 48 has been measured to ~2 
mg/mL.  
 
Figure 41. Synthesis of 5Tzl-trimer and 5Tzl-tetramer from 5Tzl-dimer, using standard deprotection conditions 
and T3P as the amide coupling reagent.   
When amide-coupling of dimers 46 and 47 was performed to produce the tetrameric structure 
49, using the same reaction conditions as earlier, surprisingly no product could be found in the 
ethyl acetate extracts from the aqueous workup, only unreacted dimer acid 47 was isolated. 
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Instead, the tetramer 49 was found in the aqueous phase after the extraction and was isolated 
by preparative HPLC. The synthesis of trimer 48 and tetramer 49 is outlined in Figure 41. 
 
6.3 Conformational analysis by quantum chemical calculations and NMR spectroscopy 
Computational studies of a heptamer structure of the 5Tzl were performed and resulted in a 
number of different possible secondary structures which are shown in Figure 42.   
 
Figure 42. Investigated secondary structures of the heptamer model and the lowest energy turn conformer, T1, 
for model Tri(Boc-Est). Formed H-bonds are marked by dashed lines. 
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Among these conformers the helical structures with a higher number of atoms in the pseudo 
ring formed via hydrogen bonding, i.e. H14, H16 and H20, were found to be more favoured 
than the lower number helical structures H8 and H10. The extended zigzag structure without 
any internal H-bonds was predicted to be the least favoured. 
To investigate any possible secondary structure of the synthesized trimer 48 and tetramer 49, 
we performed 2D NOESY experiments. The experiments were carried out in 13 and 23 mM 
DMSO-d6 solution respectively, at 25 °C, using a NOESY mixing time of 600 ms. The 
hydrogens in trimer 48 and tetramer 49 are numbered starting from the methyl ester terminal 
and going to the N-Boc terminal, and will be referred to as H1, H2... etc. This numbering 
system will be used from here and onwards in this thesis.   
 
Figure 43. Selected part of the 2D NOESY spectra of trimer 48. The experiments were carried out in 13 mM 
DMSO-d6 solution at 25 °C, using a NOESY mixing time of 600 ms and were acquired with 1024 points in the 
ƒ2 domain and 256 points in the ƒ1 domain. The data were processed using MestReNova software and baseline 
correction was applied to both dimensions using Bernstein polynomial fit (3 orders). A 90° sine bell window 
function was applied in ƒ2 and the data was zero-filled in ƒ2 domain to give a final matrix of 1024 by 1024 real 
points. 
Protons in the 2D NOESY spectra of trimer 48 were assigned by starting from the C-terminal 
and following the strong NOE cross-peaks. By combining these results with assignments 
starting from the N-terminal, almost all peaks could be assigned, except for the pairs of H6, 
H10 and H4, H8, which were overlapping. Several interresidual cross-peaks were identified, as 
seen in Figure 43 and 44, such as H3-H6, H7-H10, H7-H12, H7-H14 and H1-H14, where the latter 
two are maybe being the most interesting ones since they cannot originate from the same 
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conformer according to the calculations. Moreover, a cross-peak was found that could 
possibly originate from a NOE between H1-H6 and/or H1-H10; either of these are possible due 
to the signal overlap between H6 and H10. In similarity, a cross-peak was seen between H8-H14 
and/or H4-H14. While it is not expected that short achiral oligomers would adopt a well-
defined conformation, it is apparent from the NMR spectra that several conformers might 
coexist.  
 
Figure 44. Selected part of the 2D NOESY spectra of trimer 48 showing the end-to-end NOE. 
By using the secondary structures obtained from the theoretical calculations, the most likely 
conformers may be identified. Considering the two possibilities for the cross-peak between 
H1-H6 and/or H1-H10, out of the possible structures, the H14 helix is the only one that may fit 
the cross-peak between H1-H10, with the closest distance of 4.5Å. However, this structure 
should also generate a strong cross-peak between the methyl ester H1 and the central triazole 
proton H7, as for H14 these have a 3.0 Å distance, but this peak is missing from the spectra. 
Therefore, the cross-peak in question is more likely to originate from the H1-H6, which could 
arise mainly from other helix-forming conformers, such as H8, H10, H16 or the turn T3, 
which in the Tri(Boc-Est) model have the closest H1-H6 distances of 3.2 Å, 5.0 Å, 3.8 Å, and 
5.0 Å, respectively.      
Looking at the two possibilities for the cross-peak found between H4-H14 and/or H8-H14, the 
presence of the H7-H14 cross-peak together with the calculations dictates the only matching 
conformer for the H4-H14 NOE to be the H16-helix. At the same time, the H8-H14 may 
possibly fit for H10 and also for H20 (when looking at the heptamer model).  
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The interesting end-to-end NOE, H1-H14, could not originate from a helical-structure and is a 
strong indication for a turn-like conformer, T1-3 (T1 is shown in Figure 45). However, the 
cross-peaks H1-H6, H7-H14 and H8-H14 cannot originate from such a turn conformer. These 
assignments lead to the conclusion that trimer X exhibits neither a random conformation nor a 
single, well-defined conformer, in DMSO-solution at 25 °C. Most likely it exists in a fast 
equilibrium between at least two conformers, making H10, H16 and T1-3 the most probable 
conformers.        
 
Figure 45. The turn-like T1 conformer, exhibiting one H10-bond and one H20-bond.  
The 2D NOESY data from the NMR study of tetramer X was unfortunately not assignable 
due to extensive signal overlap between the amine methylene protons H4, H8 and H12, as well 
as the carbonyl methylene protons H6, H10 and H14, the triazole protons H7 and H11, and the 
amide protons H5, H9 and H13. These extensive overlaps render the assignment of any 
plausible secondary structures unjustified.         
 
6.4 Summary 
We have synthesized a new set of peptidomimetic compounds constructed from 1,5-
disubstituted 1,2,3-triazole (5Tzl) units. These monomer δ-amino acid derivatives were 
prepared via the RuAAC reaction, using [RuCl2Cp*]x as the catalyst, which facilitated 
purification, affording yields up to 96%. The building blocks were subsequently assembled to 
form dimeric, trimeric and tetrameric oligomers.  
The conformational analysis of trimer 48 using 2-dimensional NMR spectroscopy and 
quantum mechanical calculations, lead to the conclusion that coexisting conformers are 
present, with H10, H16 and T1-3 being the most probable conformers in DMSO solution.         
With our initial work within this foldamer-project, we can conclude that oligomers can be 
built from modular 5Tzl monomer units, synthesized via the RuAAC reaction, and serve as a 
good adaptable foldamer backbone that can adopt various secondary structures and offer 
improved properties such as water solubility. The modification of such a backbone with 
appropriate side-chains can potentially drive these foldamers into desired secondary 
structures. 
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6.5 Future plans 
Based on our initial ‘proof-of-principle’ constructs, we currently aim to expand our 
knowledge of this new set of 5Tzl oligomers, by introduction of chirality and versatile side 
chains. Moreover the amide-coupling step needs to be optimized to facilitate the production of 
more material and also of longer oligomers such as octamers. Further NMR-studies focusing 
on the effects of concentration, temperature etc, are essential to provide an improved 
understanding of the secondary structures. Finally, studies of toxicity and other potential 
bioactivity are highly desired extensions of this project.   
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7 Synthesis of Binuclear Ruthenium complexes for DNA binding studies. 
 
7.1 Introduction  
Mononuclear ruthenium complexes, such as the ones discussed in Chapter 2.4, have been 
thoroughly studied as DNA binders and have also been shown to bind to the minor groove in 
mixed DNA sequences286 and by intercalation in AT-DNA.287-288 By making the “dimer” of 
the ruthenium complexes, not only is the binding constant increased but the binding mode is 
also changed into a threading intercalation state, where the bridging ligand is stacked between 
the base-pairs and the bulky phenanthroline ligands protruding from each side of the DNA 
helix, as shown in Figur 46.289-290 This binding mode requires that one of the two ruthenium 
atoms must pass through the DNA-helix between the two strands. This obviously affects the 
kinetics of binding, and DNA threading intercalators show extremely slow association and 
dissociation kinetics compared to other DNA binding drugs. The first molecule to be 
discovered as a threading intercalator for DNA was the cytotoxic compound nogalamycin.291-
296 As there appears to be a correlation between slow dissociation kinetics and biological 
activity, threading intercalating agents are interesting as model compounds in the search for 
new DNA-targeting therapeutics. For example, the threading of  [µ-(11,11’-
bidppz)(phen)4Ru2]4+ 50 and its bipyridine analogue [µ-(11,11’-bidppz)(bpy)4Ru2]4+ have 
demonstrated a selectivity for [poly(dAdT)]2 in comparison with mixed DNA sequences, a 
property that potentially can be utilized to target parasites with high AT content in their 
genomes, such as the malaria parasite P. falsiparum.297-299     
 
Figure 46. Illustration of how a threading binuclear Ru-complex binds to a DNA-helix.  
With several binuclear ruthenium complexes synthesized and studied as DNA threading 
intercalators in the Lincoln group,289-290, 297-298, 300-301 we wanted to further increase the 
knowledge of the effect of the bridging ligand structure. Our aim was to synthesize and study 
binuclear ruthenium complexes with different lengths of the bridging ligand, to complement 
previous complexes made in our group, see Figure 47. Recently Andersson et al. have 
prepared an entirely AT-specific binuclear ruthenium complex, [µ-dppzip(phen)4Ru2]4+ 
(complex 51 in Figure 47. dppzip = 2-(dipyrido[3,2-a:2´,3´-c]phenazin-11-yl)imidazo[4,5-f]-
1,10-phenanthroline), which does not thread mixed sequence DNA at all.300-301 It was 
proposed that this increased AT-specificity arises from enhanced stress on the DNA in the 
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threaded state as the shorter bridging ligand brings the phenanthrolines closer to the DNA 
helix, resulting in steric repulsions between the complex and the DNA. The flexible AT-DNA 
can adapt its conformation in order to accommodate the threaded complex better, whereas 
such adjustments probably are associated with a large energy cost in the more rigid mixed 
sequence DNA making threading highly unfavourable. 
We were interested to investigate whether a longer complex would show the opposite 
properties as the previously studied shorter [µ-dppzip(phen)4Ru2]4+ complex 51, i.e. decreased 
AT-selectivity and slower dissociation kinetics for the DNA-binding. The introduction of an 
acetylene group between the two dppz units in [µ-(11,11’-bidppz)(phen)4Ru2]4+ 50, would 
most likely retain the geometries and the photophysical properties of the complex, while 
increasing the distance between the two charged ruthenium atoms. In addition, the 
incorporation of an ethynyl linker could also lower the energy barrier for a 0 ° torsional angle 
between the two dppz units, potentially achieving even better π-π stacking with the DNA-
bases, leading to an increased binding constant.  
 
 
Figure 47. Structure of previously studied ruthenium complexes in the Lincoln group and our two new targets at 
the bottom. The ethynyl insertion is highlighted in red.  
Similarly, we were also interested in making the ethynyl-analogue of [µ-dppzip(phen)4Ru2]4+ 
to investigate if the elongated ethynyl-analog could combine the extremely high AT-
selectivity demonstrated by the [µ-dppzip(phen)4Ru2]4+ complex 51 while attaining the slower 
kinetics and other properties of the [µ-bidppz(phen)4Ru2]4+ complex 50. The two new targets 
54 and 55 are shown in Figure 47, and the ethynyl linker is highlighted in red. 
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7.2 Synthesis of binuclear ruthenium complexes 
Our strategy to synthesize ruthenium complex 54, was to prepare the tetraaniline 60 via two 
Sonogashira coupling reactions,302-304 in order to create the ethynyl linker, which subsequently 
could be condensated reaction with enantiomerically pure Δ- or Λ-[Ru(phen)2pq]2+ 61 to 
obtain the ΔΔ- and ΛΛ- enantiomers of the target [µ-bidppze(phen)4Ru2]4+ 54 in similarity 
with previously used routes.300 Our first attempts to couple trimethylsilylacetylene with 4-
bromobenzene-1,2-diamine were unsuccessful. We modified our strategy, as outlined in 
Figure 48, by starting from 4-iodo-2-nitroaniline 56 instead, and also employing an efficient 
microwave assisted Sonogashira method,305 which afforded the TMS-protected nitroaniline 57 
in excellent yield. This is a slight improvement from a previously reported method by the 
Tour group, employed for the synthesis of molecular electronics.306-307 A simple deprotection 
of the TMS-group followed by a second Sonogashira coupling yielded the symmetric bis-
nitroaniline 59 as a red solid. Interestingly, the bis-nitroaniline 59 changes colour from red to 
yellow when dissolved in THF, or to orange when dissolved in DMSO, whereas it is 
practically insoluble in CHCl3 which enables easy purification.  
 
Figure 48. Synthesis of [µ-bidppze(phen)4Ru2]4+ (54). Reagents and conditions: (a) Ethynyltrimethyl-silane, 
Pd(PPh3)2Cl2, CuI, DIPA, DMA, microwave heating 120 °C, 10 min (99%). (b) K2CO3, MeOH/CH2Cl2, rt 80 
min (95%). (c) 4-iodo-2-nitroaniline (56), Pd(PPh3)2Cl2, CuI, DIPA, DMA, microwave heating 120 °C, 10 min 
(60%). (d) Zn, NH4Cl(aq), THF/MeOH, reflux 6 h. (e) [Ru(phen)2pq](PF6)2 (61), AcOH, CH3CN/MeOH, 22 °C. 
(f) 0.1 M SeO2(aq), CH3CN, 22 °C, 40 min (48% from 61). 
The reduction of the two nitro-groups to anilines is not as easy as it first may look. Reagents 
and reaction conditions need to be carefully selected in order to obtain selectivity for the 
nitro-group over the triple bond, meaning that catalytic hydrogenation is not an option. 
Another issue might be coordination of metals to the ortho-dianiline unit. Our best results 
were accomplished with Zn powder/NH4Cl(aq) in a refluxing mixture of THF/MeOH. Due to 
the sensitivity of tetraaminotolane 60 towards oxidation and/or polymerization, the crude 
isolated product was used directly in the condensation reaction without further purification or 
characterization. As reported previously by Westerlund et al.308 the condensation of 
[Ru(phen)2pq]2+ 61 with planar tetraaminoaryl compounds is complicated by redox side-
reactions. Compared to non-planar biphenyls, the more conjugated planar π-system of 1,2-
I
H2N
O2N
H2N
O2N
TMS
H2N
O2N
H2N
O2N
NH2
NO2
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
Ru
Ru
4+
a b c
e,f
56 57 58
54
H2N
H2N
NH2
NH2
59
d
+ 61
60
52 
 
diphenylethyne makes the corresponding tetraaminotolane 60 reactive enough to reduce the 
bidppze ligand as it is formed. Thus only a small amount of the expected [µ-
bidppze(phen)4Ru2]4+ 54 can be isolated directly from the reaction mixture, and instead a 
reduced complex is obtained. However, oxidation of the isolated hexafluorophosphate salt 
with selenium dioxide in aqueous acetonitrile proceeds smoothly to give the desired product 
54. After oxidation, the ΔΔ- and ΛΛ-enantiomers of [µ-bidppze(phen)4Ru2]4+ (54) were first 
isolated as the hexafluorophosphate salts and then converted into the chloride salts by 
precipitation with tetra-n-butylammonium chloride in acetone. 
Our strategy to synthesize all four enantiomers of the Ru-complex 55 was simply to couple 
the two halves together by a Sonogashira coupling reaction using the 2-ethynylimidazole 
complex 62 and dppzI complex 63. This strategy would control the formation of the desired 
enantiomer of the product in a simple way. However, the synthesis was not as straightforward 
as it first looked, for several reasons. The first step (shown in Figure 49), i.e. the imidazole-
forming condensation of [Ru(phen)2pq]2+ 61 and TMS-protected propargyl aldehyde with 
ammonium acetate as nitrogen source, was troublesome and only 5-10% of the TMS-
deprotected product 62 could be isolated (~5 mg). The reaction suffered heavily from side-
reactions, where formation of about 15-20 different species were detected, although most of 
these we were unable to identify.  
 
Figure 49. Acetic acid catalyzed condensation forming imidazole 62 using NH4OAc as nitrogen source.  
The synthesis of the other half was relatively straightforward, although, more care should 
have been taken when choosing the reaction conditions for the reduction of the nitro-group to 
avoid dehalogenation as a side-reaction. The condensation of the dianiline mixture proceeded 
smoothly to form [Ru(phen)2dppzI]2+ 63, as outlined in Figure 50.  
 
Figure 50. Synthesis of [Ru(phen)2dppzI]2+ 63. 
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The final step, i.e. the Sonogashira coupling of the two halves (Figure 51), was tested and the 
alkyne complex 62 was consumed, but no coupling product could be identified. The route was 
abandoned and a new strategy was engaged, proceeding via the propargylaldehyde complex 
65 and ending with the imidazole formation to couple the two halves together.    
 
Figure 51. Attempted Sonogashira cross-coupling to form the target Ru-complex 55. 
This time we started with the Sonogashira coupling reaction of 4-iodo-2-nitroaniline 56 with 
propargylalcohol, which proceeded efficiently to form nitroaniline 65 in 87 % yield (see 
Figure 52). Reduction of the nitro group was performed with Zn powder/NH4Cl(s) in 
refluxing EtOH (95%) for 1.5 hours. The crude dianiline 66 was directly used (in excess) in 
the acetic acid catalyzed condensation reaction (shown in Figure 53) with [Ru(phen)2pq]2+ 61 
at 50 °C in acetonitrile to obtain the [Ru(phen)2dppzp]2+ 67 in 74 % yield after purification on 
Al2O3.    
 
Figure 52. Synthesis of 3-(3,4-diaminophenyl)prop-2-yn-1-ol 66. 
 
Figure 53. Acid catalyzed condensation forming Ru-complex 67. 
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Interestingly, oxidation of the propargyl alcohol 67 proceeded pleasingly well with Dess-
Martin periodinane (DMP)309 in CH2Cl2/acetonitrile (3:1) at 0 °C to r.t. overnight, and the 
propargyl aldehyde 68 was produced in ~65% yield, outlined in Figure 54.  
 
Figure 54. Propargyl alcohol oxidation with Dess-Martin periodinane. Experimental procedure and 1H- and 13C-
NMR spectra of propargyl aldehyde 68 can be found in the Appendix. 
With only one final step left (Figure 55), we were optimistic in finally obtaining the target [µ-
dppzipe(phen)4Ru2]4+ 55, however, despite several careful attempts to perform the crucial 
condensation to form the imidazole, no desired product could be identified.  
 
Figure 55. Attempted condensation to form [µ-dppzipe(phen)4Ru2]4+ 55, using NH4OAc as nitrogen source.  
 
7.3 Results of the DNA-binding study  
The DNA binding of ΔΔ- and ΛΛ-[µ-bidppze(phen)4Ru2]4+ 54 was studied by various 
spectroscopic techniques described in detail in paper III and we can conclude that ΔΔ-[µ-
bidppze(phen)4Ru2]4+ 54 efficiently intercalates both AT- and ct-DNA, with a dissociation 
rate from ct-DNA that is slower than for any other ruthenium complex we have studied with 
any type of DNA. We also noted that the selectivity for AT-DNA over ct-DNA was 
decreased, even if the AT-DNA still is favoured. It was also found that it associates faster 
than the parent compound 50, as summarised in Figure 56.  
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Figure 56. Summary of the DNA-binding study. ΔΔ-[µ-bidppze(phen)4Ru2]4+ 54 demonstrated both faster 
association and slower dissociation to DNA, compared to ΔΔ-[µ-bidppz(phen)4Ru2]4+ 50. 
Moreover, we saw that although the overall selectivity for the ΛΛ-[µ-bidppze(phen)4Ru2]4+ 
54 is groove binding to AT-DNA, threading intercalation preferentially occurs in the more 
rigid ct-DNA. This shows that threading intercalation is not always selective for more flexible 
DNA structures, and that the increased DNA flexibility may instead result in better 
accommodation of rigid complexes in the groove. 
 
7.4 Summary 
DNA threading intercalators show extremely slow association and dissociation kinetics 
compared to other DNA binding drugs. As there appears to be a correlation between slow 
dissociation kinetics and biological activity, threading intercalating agents are interesting as 
model compounds in the search for new DNA targeting therapeutics. In this work we have 
synthesized the new ΔΔ- and ΛΛ-[µ-bidppze(phen)4Ru2]4+ 54 and investigated how the 
bridging ligand length affects their DNA binding properties. We have found that increasing 
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the length of the bridging ligand by introduction of the ethynyl linker improves threading by 
increasing the association rate and decreasing the dissociation rate. However, at the same time 
the selectivity for AT-rich DNA is impaired and the enantioselectivity is reversed. These 
findings are important for future design of novel DNA binding drugs with slow kinetics. 
Moreover, we have synthesized Δ- and Λ-[Ru(phen)2dppzpa]2+ 68, which can be useful 
intermediates for the synthesis of new interesting Ru-complexes in the future. 
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8 Covalent Functionalization of Carbon Nanotube Forests Grown In Situ 
on a Metal-Silicon Chip  
 
 
8.1 Aim of the project 
In this carbon nanotube (CNT) based nanotechnology project, our goal was to develop a 
method to chemically functionalize CNTs on chip, to serve as a robust platform for several 
applications, such as biosensors, microelectronics, solar cells and microtweezers. We wanted 
to introduce a functional group on the CNTs on chip, which by a simple and mild reaction, 
such as the CuAAC reaction, could be used to attach the molecule of interest for the specific 
application.      
 
8.2 Results 
The 1,3-dipolar cycloaddition reaction of azomethine ylides to activated double bonds has 
previously been applied to both C60 and single-walled carbon nanotubes (SWCNTs) in 
solution.161,310 Our strategy to functionalize the CNTs on chip is based on this reaction. Figure 
57 shows the CNTs on chip we used and a schematic drawing of the chip structure.  
 
 
Figure 57. Black squares in the picture (left) are CNT forests and the schematic drawing (center) shows how the 
CNT forests are bound to the surface on chip. A SEM micrograph of CNT forest consists of a bundle of many 
vertically aligned CNTs (right). 
The azomethine ylide can be formed in situ when an amino acid is heated in the presence of 
an aldehyde. Glycine and benzaldehyde were heated to 120 °C in dichlorobenzene to generate 
the azomethine ylide and the formed ylide was then allowed to react with double bonds in the 
CNT structures on the chip. The reaction setup is shown in Figure 58 and the reaction scheme 
is outlined in Figure 59. The procedure afforded the amine-modified CNT forest on chip, f-
CNT 1, and after a cleaning process f-CNT 1 was further derivatized by employing a simple 
amide coupling using PyBOP®311 and O-(2-azidoethyl)-O-[2-(diglycolyl-amino)- 
ethyl]heptaethylene glycol to introduce azide functionalities on the CNTs. The functionalized 
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CNT forests on chip were then analyzed using scanning electron microscope (SEM) equipped 
with an energy dispersive X-ray spectroscopy (EDS or EDX) detector. 
 
Figure 58. Left picture shows the reaction setup (after reaction) and right picture shows the cleaning setup, 
performed three times for a minimum of 1 h after every reaction step.   
The EDS spectra of f-CNT 1 and f-CNT 2 both showed a small nitrogen peak, but did not 
display any significant differences that could confirm the presence of the desired azide 
functionality. In order to verify that the CNTs were indeed successfully functionalized with 
active azide groups, we employed a CuAAC reaction to introduce a new element that could be 
detected with EDS. We chose to introduce fluorine in the form of a trifluoromethyl group on 
the alkyne, and as a control experiment the CuAAC reaction was also performed on f-CNT 1 
to verify that the expected fluorine peak in the EDS spectra of the modified chip did not 
originate from unspecific binding. A reaction scheme of the functionalization process is 
shown in Figure 59.    
 
Figure 59. Reaction scheme showing the introduction of active azide groups on CNTs on chip. (a) Glycine, 
benzaldehyde, dichlorobenzene, 120 °C for 6 to 48 h. (b) PyBOP, O-(2-azidoethyl)-O-[2-(diglycolyl-
amino)ethyl]heptaethylene glycol, DIPEA, CH2Cl2, 24 h at r.t. (c) 1-Ethynyl-4-(trifluoromethyl)benzene, CuSO4, 
sodium ascorbate, DMA/H2O 3:1, 40 h at r.t. 
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The SEM micrograph and EDS spectrum of f-CNT 3 are outlined in Figure 60, and show a 
clear fluorine peak at 0.68 keV, which indicates that the CNT forests are covalently 
functionalized with fluorine. The EDS spectrum of the control experiment showed no clear 
fluorine peak, only the iron peak nearby. These results together indicate that the fluorine 
atoms in f-CNT 3 are covalently attached. This also confirms that f-CNT 2 was successfully 
functionalized with active azide groups. 
 
 
Figure 60. SEM micrograph of the section of CNT forest where EDS was performed on f-CNT 3. 
 
8.3 Summary 
The presence of nitrogen in the EDS data on f-CNT 2 indicates successful attachment of the 
azide group. By performing a CuAAC reaction on f-CNT 2 with a fluorine source, f-CNT 3 
was successfully synthesized. The fluorine peak in the EDS spectra (Figure 60) of f-CNT 3 
together with the absence of fluorine in the control experiment, confirms the successful 
chemical reaction on the CNTs. This result also demonstrates that the azide functional group 
can be used to attach other interesting molecules to the CNTs grown on chip. 
 
8.4 Future plans  
Efforts to determine the degree of functionalization on the CNTs are currently ongoing. We 
have modified the CNTs with Fmoc protected amine groups, f-CNT 4 and f-CNT 5, as shown 
in Figure 61. By removal of the Fmoc in piperidine/DMF solution followed by determination 
of the concentration of cleaved product in the solution with absorbance measurement, 
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hopefully an estimation of the degree of functionalization can be made. After Fmoc-
deprotection of f-CNT 5, f-CNT 6 will be obtained, containing two orthogonal functional 
groups (alkyne and amine). This structure can be used to attach two different molecules of 
interest.   
 
Figure 61. Reaction scheme showing the introduction of Fmoc-protected amine groups on f-CNT 1. 
In the future, we will investigate the possibility to use this functionalized CNT-platform to 
attach biomolecules such as proteins and DNA for biosensor application and microtweezer 
experiments.  
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9 Concluding Remarks  
 
The popularity of nitrogen heterocycles in for example the pharmaceutical industry originates 
from the fact that nitrogen heterocycles display an exceptionally broad spectre of properties. 
Due to this diversity, they are one of the most commonly used structural elements in drug 
discovery. However, this variation in properties is also the reason why the chemistry and 
synthetic pathway to each heterocycle is unique. This means that research to find new 
methods, as well as to improve existing methods for the synthesis of nitrogen heterocycles 
and their chemistry, is still important for organic chemists. Many ruthenium complexes 
exhibit versatile properties which make them useful tools as catalysts, and many of them can 
also be applied in the creation of interesting nitrogen heterocycles. This makes the exploration 
of new Ru-complexes as both catalysts and as probes attractive.  
Our research on the RuAAC reaction has lead to a new practical and simple sequential one-
pot procedure, using either the [RuClCp*(PPh3)2] or the [RuCl2Cp*]x catalyst. It was also 
found that the reaction is sensitive to an excess of sodium azide and hence, the yield of the 
initial substitution reaction is crucial for a good result in the later cycloaddition. The tolerance 
of functional groups present in the substrate was investigated, and functionalities such as 
alcohols, amines, esters, fluorides, chlorides, pyridines, carbamates, amides and nitro-groups 
were found to be compatible with the reaction conditions. The effect of different solvents as 
the reaction medium was also studied. 
The RuAAC reaction was also applied in the synthesis of the 5Tzl monomer 42 in excellent 
yield, where the monomer was used in the construction towards peptidomimetic foldamers. In 
our initial study, the 5Tzl-trimer 48 was investigated by 2D NOESY, and it was found that 
several conformers are present in DMSO solution at room temperatrue, where the helical H10 
and H16 together with the turn-like structures T1-3 are the most probable ones. Future work 
in this field is planned, including improvement of the amide coupling step. Introduction of 
side-chains and chirality, together with toxicity tests also have high priority. 
We have also studied the effect of the length of the bridging ligands for DNA-threading 
intercalation of binuclear Ru-complexes. A synthesis of the ΔΔ- and ΛΛ- enantiomers of the 
new DNA-binding Ru-complex [µ-bidppze(phen)4Ru2]4+ 54 was established, and binding 
studies showed that with increased length of the bridging ligand the DNA-threading 
intercalation was improved by increasing the association rate and decreasing the dissociation 
rate. However, at the same time the selectivity for AT-rich DNA was decreased, and the 
enantioselectivity was reversed. These findings are important for future design of novel DNA 
binding drugs with slow kinetics.  
Moreover, functionalization of CNTs on a metal-silicon chip was demonstrated by covalent 
attachment of functional azide goups via diazomethine ylide cycloadditions to form 
pyrrolidines with the CNT-walls. This initial study shows the potential of this methodology 
for applications such as biosensors in the future. 
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Appendix for unpublished data 
 
3-(4-Amino-3-nitrophenyl)prop-2-yn-1-ol (65): 4-Iodo-2-nitroaniline (1.26 g, 4.6 mmol), propargyl 
alcohol (0.30 mL, 5.2 mmol), Pd(PPh3)2Cl2 (140 mg, 0.20 mmol) and CuI (38 mg, 0.20 mmol) were 
placed in a 20 mL microwave vial and THF (5 mL) was added followed by DIPA (5 mL). The vial 
was sealed and flushed with N2 for ~2 min. The reaction mixture was heated to 120 °C for 10 min in a 
microwave reactor. The reaction mixture was filtered through a plug of Celite and 1M HCl (aq) was 
added until pH ~1 was reached. The mixture was extracted with ethyl acetate/THF three times and the 
combined organic phases were washed with NaHCO3(aq) and dried over anhydrous Na2SO4. The 
drying agent was filtered off and the solution concentrated under reduced pressure. The crude product 
was purified on silica using 5% MeOH in DCM, yielding the product as an orange solid. Yield 768 mg 
(87%) 1H NMR (400 MHz, DMSO-d6, 25 °C) δ 7.95 (d, J = 2.0 Hz, 1H), 7.68 (s, 2H), 7.39 (dd, J = 
8.8, 2.0 Hz, 1H), 6.99 (d, J = 8.8 Hz, 1H), 5.28 (t, J = 5.9 Hz, 1H), 4.26 (d, J = 5.9 Hz, 3H).    
3-(3,4-Diaminophenyl)prop-2-yn-1-ol (66): 3-(4-Amino-3-nitrophenyl)prop-2-yn-1-ol 65 (100 mg, 
0.52 mmol), zinc powder (817 mg, 12.5 mmol) and NH4Cl (s) (669 mg, 12.5 mmol) were 
suspentioned in absolute EtOH (20 mL) and the reaction mixture was heated to reflux for 1.5 h. The 
reaction mixture was filtered through a syringe filter and concentrated to approximately half the 
volume and used as such directly in the next step. 
Δ-[Ru(phen)2dppzp](PF6)2 (67), (dppzp = 3-(dipyrido[3,2-a:2',3'-c]phenazin-11-yl)prop-2-yn-1-ol): 
To the crude 3-(3,4-diaminophenyl)prop-2-yn-1-ol 66 (excess) from previous step was added Δ-
[Ru(phen)2pq](PF6)2 61 (47 mg, 49µmol) dissolved in acetonitrile (3 mL), and sodium acetate (95 mg) 
and acetic acid (7 drops) were then added. The reaction mixture was heated to 50 °C for 2 h. The 
product was precipitated by dropwise addition of NH4PF6 (aq), filtered and the crude product was 
purified on Al2O3 (neutral, activity grad 1) and eluted with acetonitrile to obtain the product as a red 
solid. Yield: 39 mg (74%). 1H NMR (400 MHz, CD3CN) δ 9.63 (ddd, J = 8.2, 3.7, 1.3 Hz, 2H), 8.66 – 
8.61 (m, 4H), 8.54 (d, J = 1.5 Hz, 1H), 8.44 (d, J = 8.9 Hz, 1H), 8.29 (s, 4H), 8.23 (ddd, J = 5.3, 2.0, 
1.3 Hz, 2H), 8.13 (ddd, J = 5.0, 2.3, 1.2 Hz, 2H), 8.09 (dd, J = 8.9, 1.8 Hz, 1H), 8.04 (dd, J = 5.2, 1.3 
Hz, 2H), 7.79 (ddd, J = 8.4, 5.4, 3.2 Hz, 2H), 7.70 – 7.63 (m, 4H), 4.53 (d, J = 6.0 Hz, 2H), 3.43 (t, J = 
6.0 Hz, 1H).  
Λ-[Ru(phen)2dppzpa](PF6)2 (68), (dppzpa = 3-(dipyrido[3,2-a:2',3'-c]phenazin-11-
yl)propiolaldehyde): Dess-Martin periodane (DMP) (44 mg, 103 µmol) was dissolved in CH2Cl2 (5 
mL) and Λ-[Ru(phen)2dppzp]2+ 67 (102 mg, 93.6 µmol) dissolved in acetonitrile (2 mL) was added 
dropwise. The reaction mixture was stirred at r.t for 16 h and then quenched with 10 % Na2S2O3 (aq) 
(1 mL). The mixture was stirred at r.t. for 30 min and saturated NH4PF6(aq) was added. The mixture 
was extracted with CH2Cl2 (three times) and filtered through a phase separator and evaporated. The 
crude product was purified on Al2O3 (neutral, activity grade 1) using a step wise gradient from 10 to 
50% acetonitrile in CH2Cl2 to obtain the product as a red solid. Yield: 67 mg (65%). 1H NMR (400 
MHz, CD3CN): δ 9.65 – 9.60 (m, 2H), 9.54 (s, 1H), 8.80 (d, J = 1.4 Hz, 1H), 8.67 – 8.62 (m, J = 8.3, 
5.8, 1.2 Hz, 4H), 8.52 (dd, J = 8.8, 0.4 Hz, 1H), 8.29 (s, 4H), 8.26 – 8.20 (m, 3H), 8.15 (dd, J = 5.4, 
1.3 Hz, 2H), 8.04 (dd, J = 5.2, 1.3 Hz, 2H), 7.82 – 7.78 (m, 2H), 7.72 – 7.63 (m, 4H). 13C NMR (101 
MHz, CD3CN): δ 177.57, 154.71, 154.64, 153.26, 152.97, 151.25, 151.16, 147.86, 147.79, 143.26, 
142.01, 141.29, 141.24, 137.01, 136.95, 135.37, 134.18, 133.68, 133.52, 131.08, 131.06, 130.61, 
130.46, 130.45, 128.10, 128.08, 127.39, 127.36, 125.94, 125.88, 123.07, 90.92, 90.19. 
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3-(4-Amino-3-nitrophenyl)prop-2-yn-1-ol (65)
 Δ-[Ru(phen)2dppzp](PF6)2 (67) 
  
 
3.03.23.43.63.84.04.24.44.64.85.05.25.45.65.86.06.26.46.66.87.07.27.47.67.88.08.28.48.68.89.09.29.49.69.8
f1 (ppm)
A (ddd)
9.63
B (m)
8.64
C (d)
8.54
D (d)
8.44
E (s)
8.29
F (ddd)
8.23
G (ddd)
8.13
H (dd)
8.09
I (dd)
8.04
J (ddd)
7.79
K (m)
7.67
L (d)
4.53
M (t)
3.43
1
H NMR (400 MHz, CD3CN) δ 9.63 (ddd, J = 8.2, 3.7, 1.3 Hz, 2H), 8.66 – 8.61
(m, 4H), 8.54 (d, J = 1.5 Hz, 1H), 8.44 (d, J = 8.9 Hz, 1H), 8.29 (s, 4H), 8.23 (ddd,
J = 5.3, 2.0, 1.3 Hz, 2H), 8.13 (ddd, J = 5.0, 2.3, 1.2 Hz, 2H), 8.09 (dd, J = 8.9, 1.8
Hz, 1H), 8.04 (dd, J = 5.2, 1.3 Hz, 2H), 7.79 (ddd, J = 8.4, 5.4, 3.2 Hz, 2H), 7.70 –
7.63 (m, 4H), 4.53 (d, J = 6.0 Hz, 2H), 3.43 (t, J = 6.0 Hz, 1H).
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Λ-[Ru(phen)2dppzpa](PF6)2 (68) 
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